RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,046,969 | -25.4% | 3,810,579 | +11.5% | 0.39% | -17.2% |
| Q2 2023 | $42,938,483 | -2.4% | 3,418,669 | +28.0% | 0.47% | -5.8% |
| Q1 2023 | $43,978,145 | +9.6% | 2,670,197 | -0.6% | 0.50% | +4.4% |
| Q4 2022 | $40,139,462 | -28.6% | 2,686,711 | +6.9% | 0.48% | -30.5% |
| Q3 2022 | $56,204,000 | +18.1% | 2,512,468 | -11.6% | 0.69% | +26.7% |
| Q2 2022 | $47,581,000 | -21.5% | 2,840,673 | +40.3% | 0.54% | +2.6% |
| Q1 2022 | $60,612,000 | -2.9% | 2,025,114 | -0.4% | 0.53% | +5.8% |
| Q4 2021 | $62,443,000 | +347.3% | 2,033,324 | +359.3% | 0.50% | +359.6% |
| Q3 2021 | $13,959,000 | +2.5% | 442,733 | +19.0% | 0.11% | +5.8% |
| Q2 2021 | $13,619,000 | +16.1% | 372,195 | +9.7% | 0.10% | +17.0% |
| Q1 2021 | $11,734,000 | -17.0% | 339,436 | -0.2% | 0.09% | -20.0% |
| Q4 2020 | $14,142,000 | -3.7% | 340,277 | -1.4% | 0.11% | -21.4% |
| Q3 2020 | $14,692,000 | – | 344,954 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |